High fat diet aggravates cardiomyopathy in murine chronic Chagas disease

Kezia Lizardo1, Janeesh Plakkal Ayyappan1, Min-Hui Cui2

  • 1Department of Microbiology, Biochemistry and Molecular Genetics, Public Health Research Institute, New Jersey Medical School, Newark, USA.

Microbes and Infection
|August 3, 2018
PubMed

Insights

High-fat diets exacerbate chronic Chagas disease cardiac pathology by disrupting lipid metabolism and increasing oxidative stress in mice. This contrasts with acute infection, where such diets offered protection against heart damage.

Area of Science:

  • Cardiovascular Disease Research
  • Infectious Disease Epidemiology
  • Nutritional Science

Background:

  • Chagas disease, caused by Trypanosoma cruzi, is a significant cause of heart disease in Latin America.
  • A dietary shift towards Western-style, high-fat diets (HFD) is occurring in endemic regions.
  • Previous studies showed HFD protected against acute Chagas disease cardiac damage.

Purpose of the Study:

  • To investigate the impact of HFD on indeterminate and chronic stages of Chagas disease.
  • To elucidate the effects of HFD on cardiac pathology during later infection stages.
  • To understand HFD's role in myocardial inflammation and dysfunction in chronic Chagas disease.

Main Methods:

  • Utilized a mouse model of Trypanosoma cruzi infection.
  • Administered a high-fat diet during the indeterminate and chronic phases of infection.
  • Assessed cardiac inflammation, vasculopathy, and lipid metabolism.

Main Results:

  • High-fat diet exacerbates cardiac pathology in late-stage chronic Chagas disease.
  • HFD perturbs lipid metabolism in the heart during chronic infection.
  • HFD induces oxidative stress, worsening cardiac dysfunction.

Conclusions:

  • Dietary fat content significantly influences Chagas disease progression and cardiac outcomes.
  • HFD is detrimental in chronic Chagas disease, unlike its protective role in acute infection.
  • Findings highlight the complex interplay between diet and Chagas disease pathogenesis.

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
575
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
503
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
740
Chronic Obstructive Pulmonary Disease01:24

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.6K
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
558
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
4.6K